How the Republican and Democrat presidential candidates might appeal to voters on this topic is starting to be seen.
The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
Thu, Sep 8, 2022 11am EST | 8am PST | 4pm BST | 5pm CEST Digitalization & leveraging real-time data are key for biopharma process improvement. Insilico models and soft-sensors boost biopharma performance to unprecedented levels.
This application note explores the feasibility of utilizing the scale-X carbo bioreactor as a solution for seed train intensification.
Fully automated enzyme analysis can ease a persistent bottleneck in biocatalyst development for bio/pharmaceutical applications.
Change of lot or extension of reference standard shelf-life is considered low risk and should be downgraded from prior-approval to being managed in the Pharmaceutical Quality System (PQS) only based on a science and risk-based approach.
The increased number of regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.
Public health challenges have highlighted the need for agility in maintaining the quality of medicines.
AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for sterile liquid and freeze-dried forms.
In this article, the authors explored the elimination of a water rinse and blow down following the caustic wash step, examining potential safety considerations, the effect on the quality of the cleaning process, and the potential benefit of implementing this change.
Critical considerations for deploying smart, fast, and flexible Life Sciences facilities
This article focuses on drawing parallels between ICH Q14/Q2(R2), United States Pharmacopeia (USP) <1220>, and International Organization for Standardization/International Electrotechnical Commission (ISO/IEC) 17025:2017.
The biopharmaceutical landscape of India is transforming in terms of regulatory policies, product development, and affordability.
The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.
The panel highlights the need for continued research, collaboration between stakeholders, and a strategic approach to leveraging mRNA's capabilities to address unmet clinical needs.
Advanced LC technologies can streamline the review process for LC equipment maintenance.
Quality quartets support an integrated and stable combination of commissioning and qualification and quality risk management processes.
The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.
Vetting contract fill finish manufacturers is about more than their capacity. Jubilant HollisterStier advises on what to look for in a sterile fill finish partner.
A structured assessment process can determine compliance to lifecycle process-validation requirements for biopharmaceuticals.
The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.
The complete online database of ACS Reagent Chemicals is now available.
In this article, the authors explored the elimination of a water rinse and blow down following the caustic wash step, examining potential safety considerations, the effect on the quality of the cleaning process, and the potential benefit of implementing this change.
The BIOne 10L SUB is highly innovative with expanded processing capabilities, ideal for scale-down modeling, material generation, and process optimization.
In this article, a simple chromatographic model is proposed that is capable of predicting the impact of pH and ionic strength on HIC chromatograms.
Advances in preclinical development play a crucial role in reducing cost for developing biosimilars.
Webinar Date/Time: Thu, Thu, Apr 18, 2024 11:00 AM EDT
Workforce training is crucial for biopharmaceutical manufacturing.
Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.
A single protein or gene expression product can exist in multiple proteoforms due to alternative splicing, point mutations, post translational modifications and endogenous proteolysis.